-
Mitochondrial CAT-Tailing in Glioblastoma Growth
2026-09-17
The reference study identifies mitochondrial stress-induced carboxyl-terminal alanine and threonine tailing as a functional ribosome-associated quality-control response that supports glioblastoma survival, migration, and overgrowth. Its experiments connect CAT-tail-dependent remodeling of ATP synthase-associated mitochondrial behavior with membrane-potential maintenance and resistance to apoptosis, providing a mechanistic framework for studying mitochondrial stress in glioblastoma.
-
Lovastatin as a Translational Probe of Cell Fate
2026-09-17
Lovastatin is more than a cholesterol biosynthesis inhibitor: as an HMG-CoA reductase inhibitor, it provides a practical way to interrogate how mevalonate metabolism shapes proliferation, apoptosis, tissue remodeling, and macrophage clearance. This thought-leadership perspective connects those mammalian research applications with the systems-level logic of KNUCKLES-controlled floral meristem termination while clearly defining the evidence and translational limits of that cross-domain comparison.
-
EZ Cap EGFP mRNA 5-moUTP Workflow Guide
2026-09-17
Build more interpretable reporter experiments with a Cap1-capped, 5-moU-modified EGFP transcript designed for stable translation and reduced innate immune recognition. This guide connects cell-based expression assays with nanoparticle delivery, in vivo imaging, and practical troubleshooting.
-
Bazedoxifene Workflows for SERM Research
2026-09-16
Bazedoxifene supports tissue-selective estrogen receptor studies, bone mineral density enhancement models, and an emerging antimalarial repurposing workflow. This practical guide connects formulation, ER pathway assays, parasite-stage analysis, controls, and troubleshooting without conflating preclinical findings with clinical evidence.
-
METTL16–SENP3–LTF Axis in HCC Ferroptosis
2026-09-15
Wang et al. identify a METTL16–SENP3–LTF regulatory axis that protects hepatocellular carcinoma from ferroptosis by reducing the labile iron pool. Their integrated cell, organoid, mouse-model, molecular, and clinical analyses position this pathway as a mechanistic framework for studying ferroptosis resistance and tumor progression.
-
Ibrutinib (PCI-32765) Experimental Workflow
2026-09-15
Build reproducible B-cell receptor signaling inhibition assays with Ibrutinib (PCI-32765), from stock preparation through washout, viability, and pathway readouts. The workflow also explains how findings from ATRX-deficient glioma research can inform assay stratification without overstating evidence for BTK inhibition outside B-cell models.
-
2X HyperFusion High-Fidelity Master Mix Workflow
2026-09-14
Build accurate cloning, construct-verification, and CRISPR assay workflows with a ready-to-use proofreading mix designed for robust amplification. This guide connects high-fidelity PCR decisions to the CD47-targeting nanomedicine study while clearly separating validated product capabilities from practical workflow recommendations.
-
Cell-Surface LAMP1 as a Senescence Marker
2026-09-14
This 2025 Aging Cell study identifies cell-surface LAMP1 as a membrane-accessible marker associated with senescence across human and mouse models, including aging and bleomycin-induced lung fibrosis. Its combination of marker validation, lung-tissue transcriptomics, and a dual antibody–drug conjugate experiment provides a framework for detecting and selectively eliminating senescent cells, while also highlighting the need for further tissue and in vivo validation.
-
Proteostasis as a Translational Oncology Lever
2026-09-13
Bortezomib (PS-341) is more than a cytotoxic benchmark: it is a reversible 20S proteasome inhibitor that can help researchers connect protein turnover, apoptosis, and metabolic state. This article translates recent mitochondrial proteostasis findings into a disciplined framework for oncology experiments without overstating an unproven mechanistic link.
-
Phalloidin (B7678): Practical F-Actin Workflow
2026-09-12
Phalloidin (B7678) is a high-affinity F-actin-binding reagent for preserving and visualizing filament organization in fixed or permeabilized samples. It is suited to endpoint cytoskeleton analysis, but not to live-cell imaging or experiments that require reversible actin interactions.
-
Torin2: Precision mTOR Inhibitor Workflows
2026-09-12
Torin2 combines subnanomolar mTOR potency with a practical workflow for pathway inhibition, viability profiling, and apoptosis assay design. This guide shows how to use it in cancer research, including medullary thyroid carcinoma models, while avoiding solubility, timing, and interpretation errors.
-
Chlorambucil: From DNA Damage to Better Translation
2026-09-11
Chlorambucil is more than a legacy chemotherapy reference compound: it is a practical model for linking DNA crosslinking, assay interpretation, and translational decision-making. This article outlines how researchers can use its mechanistic clarity and model-dependent cytotoxicity to build more informative oncology workflows.
-
Coelenterazine Workflows for ROS Reporter Assays
2026-09-11
Coelenterazine unites coelenterate luciferase reporting with chemiluminescent detection of superoxide anion and peroxynitrite. This guide shows how to separate reporter activity from oxidative chemistry across AVP assays, BRET, high-throughput screening, and cancer-associated reactive oxygen species imaging.
-
Cy5-UTP Maps RNA Condensates to Translational Insight
2026-09-10
STAU2 condensates coordinate mRNA transport and local translation in developing neurons. This thought-leadership guide shows how Cy5-UTP and Cyanine 5-uridine triphosphate can turn that mechanism into an experimentally testable workflow for FISH, RNA probe synthesis, and translational research.
-
Ginsenoside Rg1 for Reliable Cell Assays
2026-09-10
Learn how Ginsenoside Rg1, SKU N1613, can support reproducible viability, cytotoxicity, apoptosis, and neuroprotection research. This scenario-based guide covers solvent controls, protocol design, interpretation, and product-selection criteria grounded in product data and recent in vivo evidence.